Isoprenoids and Cancer
1. Global understanding of isoprenoids, their metabolism, and interface with disease.
2. Relate the clinical activity to underlying mechanisms of action(s) at the cellular and biochemical levels.
3. Know the relatively unique clinical pharmacology features associated with these agents.
4. Understand opportunities for new applications of these agents.
Presentation: 62 minutes
Hohl, MD, PhD, Raymond J., "Isoprenoids and Cancer" (2014). Kimmel Cancer Center Papers, Presentations, and Grand Rounds. Paper 14.